title: [Hypertrophic pachymeningitis and ophthalmological disturbances: description of two case reports].
abstract: METHODS
  We report two cases of hypertrophic pachymeningitis with ophthalmological disturbances. One patient suffered from hypertrophic pachymeningitis supposedly secondary to a focal neurosarcoidosis and had a sixth nerve paresis. The second patient suffered from a diffuse idiopathic hypertrophic chronic pachymeningitis (a rare form) and displayed disturbances in vision and ocular motility.
  
  
  CONCLUSIONS
  Hypertrophic pachymeningitis is a condition with a wide spectrum of etiologies and clinical manifestations, and needs to be considered as the cause in patients with alterations in ocular motility
authors.affiliation: Servicio de Oftalmología, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, España. jesusparejaesteban@gmail.com
authors.forename: J
authors.initials: J
authors.lastname: Pareja-Esteban
authors.forename: S
authors.initials: S
authors.lastname: Gutiérrez-Solana
authors.forename: M
authors.initials: M
authors.lastname: Cedazo
authors.forename: B
authors.initials: B
authors.lastname: Sánchez-Cordón
authors.forename: M
authors.initials: M
authors.lastname: Gamo-Gallego
authors.forename: M A
authors.initials: MA
authors.lastname: Teus
mesh_terms: D020434:Abducens Nerve Diseases / Q000150:complications; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D003391:Cranial Nerves; D004388:Dura Mater / Q000473:pathology*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D008297:Male; D008581:Meningitis / Q000150:complications* / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D009422:Nervous System Diseases / Q000150:complications; D015835:Ocular Motility Disorders / Q000209:etiology*; D009902:Optic Neuritis / Q000209:etiology*; D010243:Paralysis / Q000150:complications; D012507:Sarcoidosis / Q000150:complications; D013997:Time Factors; D015899:Tomography, Emission-Computed, Single-Photon; D014057:Tomography, X-Ray Computed; D014786:Vision Disorders / Q000209:etiology*
chemical_list: D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D001379:Azathioprine; D008775:Methylprednisolone